Early Day Motion 1468

New blood cancer drug

Tabled 16 June 2025 by Clive Jones

That this House notes that blood cancer is the UK's third largest cancer killer and that myeloma remains an incurable blood cancer; welcomes the recent announcement that the National Institute for Health and Care Excellence have approved belantamab mafodotin to treat myeloma; further welcomes that eligible patients in the UK will be the first in the world to have access to the innovative drug; congratulates the hard work of the scientists who are at the forefront of fighting cancer; and calls on the Government to make the UK a superpower in cancer research.

Signatories (28)